Jacquelyn Sandell
Vermogen: 121 797 $ op 30-06-2026
Vermogen: 121 797 $ op 30-06-2026
Jacquelyn Fahey Sandell is currently Secretary & Chief Legal Officer at Jounce Therapeutics, Inc. since 2019 and Chief Legal Officer at Voyager Therapeutics, Inc. since 2023.
Formerly, Ms. Sandell was Associate General Counsel at Millennium Pharmaceuticals, Inc. from 2011 to 2015, Vice President & General Counsel at Vericel Corp., and Senior Corporate Counsel at Genzyme Corp.
from 2005 to 2011.
Education includes undergraduate studies at Duke University and graduate studies at Boston University School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 34.799 ( 0,06% ) | 121 797 $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Algemeen Adviseur | 17-09-2019 |
| VOYAGER THERAPEUTICS, INC. | Algemeen Adviseur | 10-07-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Corporate Officer/Principal | 01-01-2015 |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Algemeen Adviseur | 01-01-2011 |
| VERICEL CORPORATION | Algemeen Adviseur | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 7 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Vericel Corp.
Vericel Corp. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which manufactures and markets two advanced cell therapy products for sports medicine and severe burn care | Health Technology |
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Law
Boston University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jounce Therapeutics, Inc.
Jounce Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage immunotherapy company that develops therapies to treat cancer | Health Technology |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau